Drug-labels.com

Auro-Mirabegron: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
50 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Auro-Mirabegron

ABOUT THIS MEDICATION

What the medication is used for:

Auro-Mirabegron treats the symptoms of an overactive bladder such as:

  • suddenly needing to empty your bladder (called urgency)
  • having to empty your bladder more than usual (called urinary frequency)
  • not being able to control when you empty your bladder (called urgency incontinence)

What it does:

Auro-Mirabegron contains mirabegron. It works by relaxing the bladder smooth muscle, thereby reducing the symptoms of an overactive bladder.

When it should not be used:

  • you have very high uncontrolled blood pressure
  • if you are allergic to mirabegron or any of the ingredients in Auro-Mirabegron
  • women who are pregnant or breastfeeding

What the medicinal ingredient is:

Mirabegron

What the nonmedicinal ingredients are:

Butylated hydroxytoluene, hydroxypropyl cellulose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyethylene oxide.

The tablet film coating contains hypromellose, macrogol and iron oxide yellow.

What dosage forms it comes in:

Extended-release tablets, 50 mg.

WARNINGS AND PRECAUTIONS

BEFORE you use Auro-Mirabegron talk to your doctor or pharmacist if:

  • you have problems emptying your bladder or if you have weak urine stream
  • you are pregnant or trying to become pregnant
  • you are breastfeeding or planning to breastfeed
  • you have severe liver problems
  • you have severe kidney problems
  • you have an eye problem called Glaucoma
  • you have high blood pressure or a history of high blood pressure
  • you have any heart disorder, including an irregular heartbeat, an abnormal electrical signal called “prolongation of the QT interval” or a known history of QT interval prolongation
  • you have a history of ischemic heart disease or a heart rate that is higher than normal

Auro-Mirabegron should not be given to patients under 18 years of age.

INTERACTIONS WITH THIS MEDICATION

Tell your doctor about all the medicines you take, including prescription and non prescription medicines, vitamins, and herbal supplements. Auro-Mirabegron may affect the way other medicines work, and other medicines may affect how Auro-Mirabegron works. You may need to change the dosage or stop taking one of the medicines.

Auro-Mirabegron may interact with the following medications:

  • Propafenone, or Flecainide, drugs used to treat irregular heartbeats
  • Digoxin
  • Drugs known to increase the heartbeat or elevate blood pressure
  • Drugs known to prolong the QT/QTc interval and/or cause torsade de pointes

PROPER USE OF THIS MEDICATION

Usual starting dose:

25 mg once daily with or without food. The tablet should be swallowed whole with a glass of water. Do not crush or chew the tablet. Based upon your response and tolerability, your doctor may increase your dose to 50 mg once daily. The maximum dose for Auro-Mirabegron is 50 mg once daily.

Note: Auro-Mirabegron is only available in 50 mg tablets.

Overdose:

If you think you, or a person you are caring for, have taken too much Auro-Mirabegron, contact a healthcare professional, hospital emergency department, regional poison control centre or Health Canada’s toll-free number, 1-844 POISON-X (1-844-764-7669) immediately, even if there are no signs or symptoms.

Missed Dose:

If you forget to take your medicine, then take your next dose at the normal time. Do not take a double dose to make up for a forgotten dose. If you miss several doses, tell your doctor and follow the advice given to you.

SIDE EFFECTS AND WHAT TO DO ABOUT

THEM

As with all medications, Auro-Mirabegron can cause side effects. The possible common side effects are as follows:

  • Increased blood pressure
  • Cold symptoms (Nasopharyngitis)
  • Urinary tract infection
  • Constipation
  • Diarrhea
  • Dizziness
  • Headache
  • Nausea
  • Itching

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
Uncommon

Rash / Urticaria (hives)

Urinary Retention

(the inability to empty your bladder)

Atrial fibrillation (rapid and irregular heart beat)

Cerebrovascu lar accident (stroke)

✓

✓

✓

✓

RareAngioedema (swelling of the face or tongue, difficulty breathing)✓

This is not a complete list of side effects. For any unexpected effects while taking Auro-Mirabegron, contact your doctor or pharmacist.

HOW TO STORE IT

Preserve in tight containers. Store at room temperature (15°C - 30°C). Protect from moisture.

Keep out of the reach and sight of children.

Reporting side effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (canada.ca/drug-device-reporting) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your healthcare professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

If you want more information about Auro-

Mirabegron:

  • Talk to your healthcare professional.
  • Find the full product monograph that is prepared for healthcare professionals and includes this Consumer Information by visiting the Health Canada Drug Product Database website: (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html); the manufacturer’s website http://www.auropharma.ca, or by calling 1- 855-648-6681.

3700 Steeles Avenue West, Suite # 402

Woodbridge, Ontario, L4L 8K8,

Canada.

Date of Preparation: JAN 29, 2026

.

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02564955

Revision date stated in the text: January 29, 2026

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Auro-Mirabegron

Rx or OTC
Prescription (Rx)?
DIN 02564955
Schedule(s) PRESCRIPTION
Active ingredient(s) Mirabegron 50 MG
Dosage form(s) Tablet (Extended-Release)
Route(s) of administration Oral
Drug class (WHO ATC)
  1. G Genito urinary system and sex hormones
    1. G04 Urologicals
      1. G04B Urologicals
        1. G04BD Drugs for urinary frequency and incontinence
          1. G04BD12 Mirabegron
Company AURO PHARMA INC
Current status Marketed
Current status date June 22, 2026

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.